Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.

about

New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.

P2860

Q47162060-235C59C5-8C53-4726-BF3A-CDB510524F71

P2860

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.

Item

http://www.wikidata.org/entity/Q41930000

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hepatitis C virus positive dif ...... and lack BCL2 translocations.

@en

type

Item

label

Hepatitis C virus positive dif ...... and lack BCL2 translocations.

@en

prefLabel

Hepatitis C virus positive dif ...... and lack BCL2 translocations.

@en

P1476

Hepatitis C virus positive dif ...... and lack BCL2 translocations.

@en

P2093

Andrés J M Ferreri

http://www.w3.org/2001/XMLSchema#string

Carlo Visco

http://www.w3.org/2001/XMLSchema#string

Emanuele S G D'Amore

http://www.w3.org/2001/XMLSchema#string

Eric D Hsi

http://www.w3.org/2001/XMLSchema#string

Jinfen Wang

http://www.w3.org/2001/XMLSchema#string

Karen Dybkær

http://www.w3.org/2001/XMLSchema#string

Ken H Young

http://www.w3.org/2001/XMLSchema#string

L Jeffrey Medeiros

http://www.w3.org/2001/XMLSchema#string

Lijuan Deng

http://www.w3.org/2001/XMLSchema#string

Maria Chiara Tisi

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.

Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.

P2888

bjc.2017.345

P304

1685-1688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.345

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Alexandar Tzankov

Santiago Montes-Moreno

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091915438

http://www.w3.org/2001/XMLSchema#string

P698

28949959

http://www.w3.org/2001/XMLSchema#string

P932

5729442

http://www.w3.org/2001/XMLSchema#string

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.

about

P2860

P2860

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932